Sandra Porcile Rojas-Caro

Sandra Porcile Rojas-Caro

Director/Board Member at VIÑA CONCHA Y TORO S.A.
57 year
Health Technology
Consumer Non-Durables
Retail Trade

Profile

Sandra Porcile Rojas-Caro is currently an Independent Director at Viña Concha y Toro SA, starting in 2026.
Former roles include Independent Director at Ripley Corp.
SA from 2020 to 2025, Chief Medical Officer at Spyre Therapeutics, Inc., VP-Clinical Research & Exploratory Development at Synageva BioPharma Corp.
from 2013 to 2014, Chief Medical Officer at NeuBase Therapeutics, Inc. from 2021 to 2022, and Chief Medical Officer at Gemini Therapeutics, Inc. Education includes undergraduate and doctorate degrees from Pontificia Universidad Católica de Chile.

Sandra Porcile Rojas-Caro active positions

CompaniesPositionStart
VIÑA CONCHA Y TORO S.A. Director/Board Member 2026-04-20

Former positions of Sandra Porcile Rojas-Caro

CompaniesPositionEnd
RIPLEY CORP S.A. Director/Board Member 2025-04-29
NEUBASE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2022-10-27
GEMI THER Chief Tech/Sci/R&D Officer -
SPYRE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
SYNAGEVA BIOPHARMA CORP Chief Tech/Sci/R&D Officer -
See the detail of Sandra Porcile Rojas-Caro's experience

Training of Sandra Porcile Rojas-Caro

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

45

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Non-Durables

Health Technology

Retail Trade

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Sandra Porcile Rojas-Caro
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!